Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bausch & Lomb taking $10 mil. charge for settlement of lens marketing class action suit.

This article was originally published in The Gray Sheet

Executive Summary

BAUSCH & LOMB TO TAKE $10 MIL. CHARGE FOR CONTACT LENS CLASS ACTION SETTLEMENT, the company announced Aug. 1. The lawsuit, given class action status in Birmingham, Alabama on Nov. 1, 1994, related to the firm's marketing of its SeeQuence 2, Medalist, Optima FW and Criterion Ultra FW soft contact lenses.

You may also be interested in...

J&J AcuVue Class Action Settlement Immaterial Due To Existing Reserves

A proposed settlement of a Johnson & Johnson AcuVue contact lens class action suit valued at up to $860 mil. will not have a material impact on financial results due to existing litigation reserves, the firm says. A preliminary hearing on the settlement proposal, announced April 17, is set for May 18.

Unilever Hit With Class Action Over Mercury-Laced Pond’s Cream Originating In Mexico

According to the plaintiff, Unilever’s Pond’s Rejuveness Anti-Wrinkle Cream is defective insofar as tested product has been found to contain unlabeled mercury, constituting negligence that has resulted in user injuries. The plaintiff seeks certification of a transnational class and compensatory and punitive damages, among other relief.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts